Burning Rock Biotech Ltd. (BNR)
9.80
-0.52
(-5.04%)
USD |
NASDAQ |
Aug 25, 16:00
9.65
-0.15
(-1.53%)
Pre-Market: 19:59
Burning Rock Biotech EPS Diluted (Quarterly) : -0.2399 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.2399 |
| December 31, 2025 | -0.2063 |
| September 30, 2025 | -0.2173 |
| June 30, 2025 | -0.1246 |
| March 31, 2025 | -0.1724 |
| December 31, 2024 | -1.094 |
| September 30, 2024 | -0.4831 |
| June 30, 2024 | -1.454 |
| March 31, 2024 | -1.649 |
| December 31, 2023 | -2.192 |
| September 30, 2023 | -2.360 |
| June 30, 2023 | -1.824 |
| March 31, 2023 | -2.644 |
| December 31, 2022 | -2.968 |
| September 30, 2022 | -3.251 |
| Date | Value |
|---|---|
| June 30, 2022 | -3.780 |
| March 31, 2022 | -3.940 |
| December 31, 2021 | -3.761 |
| September 30, 2021 | -2.528 |
| June 30, 2021 | -3.030 |
| March 31, 2021 | -2.543 |
| December 31, 2020 | -2.274 |
| September 30, 2020 | -1.770 |
| June 30, 2020 | -3.786 |
| March 31, 2020 | -1.089 |
| December 31, 2019 | -1.836 |
| September 30, 2019 | -0.9054 |
| June 30, 2019 | -0.9571 |
| March 31, 2019 | -0.9448 |
| December 31, 2018 | -0.9487 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -0.4557 |
| BioRestorative Therapies, Inc. | -0.1215 |
| CareDx, Inc. | 2.071 |
| Natera, Inc. | -0.4674 |
| Exagen, Inc. | -0.1323 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.523M |
| Revenue (Quarterly) | 15.59M |
| Total Expenses (Quarterly) | 18.11M |
| Enterprise Value | 28.51M |
| Gross Profit Margin (Quarterly) | 72.27% |
| Profit Margin (Quarterly) | -16.19% |
| Earnings Yield | -8.04% |
| Normalized Earnings Yield | -8.041 |